2,3,7,8-Tetrachlorodibenzo-p-Dioxin Impairs Differentiation of Normal Human Epidermal Keratinocytes in a Skin Equivalent Model To the Editor: 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is an environmental pollutant that is taken up via the food chain and accumulates in fat tissue. In humans, intoxication with TCDD causes chloracne, a severe skin disease resulting in disfiguring scarring (Geusau et al, 1999 (Geusau et al, , 2001 . In the past, various experimental approaches have been adapted to study the effect of TCDD on keratinocytes (KC) and skin. In utero exposure of murine fetuses led to an accelerated terminal differentiation in fetal mouse skin (Loertscher et al, 2002) . Treatment of non-transformed human KC cultures with TCDD resulted in enhanced differentiation, determined by an increase of involucrin expression and modulation of expression of a number of growth-regulatory proteins (Gaido and Maness, 1994) . One study on the effects of TCDD was performed with a spontaneously immortalized human KC cell line in a three-dimensional (3D) skin equivalent (SE) model, where TCDD caused acceleration of differentiation as determined by morphological characterization and by immunohistochemistry for several differentiation-specific protein markers; neither an influence on proliferation nor an induction of apoptosis was observed (Loertscher et al, 2001) .
In this study, we investigated the effect of TCDD on normal human epidermal KC grown in a 3D model under differentiating conditions (Stark et al, 1999; Rendl et al, 2002) . After exposure of SE to TCDD at concentrations of 10 À8 and 10 À7 M for 1 wk, we quantified alterations of the KC differentiation process by western blot analysis with antibodies against selected differentiation markers.
In vitro reconstructed SE were generated according to the protocol of Stark and colleagues with modifications described previously (Stark et al, 1999; Rendl et al, 2002) . Starting on the day of lifting the culture to the air interface, culture medium for SE was supplemented with either TCDD (AccuStandard Inc., New Haven, Connecticut) (10 À7 and 10 À8 M) or vehicle every 2 d and culture was continued for up to 7 d. After 3 and 7 d of culture samples were taken by punch biopsy for hematoxylin & eosin staining and immunohistochemistry, performed as described previously. SE were also lyzed in a buffer containing 6 M urea 62.5 mM Tris/HCl, pH 6.8, 2% SDS, and 10% glycerol and subjected to western blot analysis as described previously (Rendl et al, 2002) . The following antibodies were used at the indicated concentrations: goat polyclonal anti-CYP1A1 (Gentest Corporation, Woburn, Massachusetts) 1:500, mouse monoclonal anti-involucrin (NeoMarkers, Fremont, California) 1:1000, mouse monoclonal anti-filaggrin (Biomedical Technologies, Stoughton, Massachusetts) 1:500, rabbit polyclonal anti-Id-1 (Santa Cruz Biotechnology, Heidelberg, Germany) 1:1000, mouse monoclonal anti-p63 (Oncogene Research Products, Boston, Massachusetts) 1:300, mouse monoclonal anti-p16 (NeoMarkers) 1:250, mouse monoclonal anti-K1/10/11 (Cymbus Biotechnology, Hampshire, UK) 1:1000, and a rabbit polyclonal antibody that we had raised against recombinant human caspase-14 (Alibardi et al, in press) .
The most prominent effect of TCDD was an increase of thickness of the stratum corneum with parakeratosis and a reduction of viable cell layers after 7 d of treatment, compared with vehicle-treated samples (Fig 1) . A complete loss of the granular layer was visible both on days 3 and 7 of incubation with TCDD.
For quantitative comparison of SE treated and untreated with TCDD, the abundance of selected marker proteins was determined by western blotting. Expression of cytochrome P450 1A1 (CYP1A1), a dioxin-responsive gene (Xu et al, 2000) , was strongly induced in a concentration-dependent manner (Fig 2) , indicating the validity of the model used. TCDD decreased expression of p63 and Id-1, transcription factors that are downregulated during terminal KC differentiation (Langlands et al, 2000; Koster and Roop, 2004) , at a concentration of 10 À8 M and virtually abrogated their expression at 10 À7 M. In line with previous reports on overexpression of Id-1 in KC (Nickoloff et al, 2000) , modulation of the amount of Id-1 was accompanied by an inverse regulation of p16 that was concentration-dependently upregulated by TCDD (Fig 2) .
Expression of markers of KC differentiation was heterogenous: whereas the abundance of involucrin was increased by TCDD, the levels of keratins 1 and 10 were decreased after 7 d of TCDD treatment (Fig 2) . Caspase-14, a protease implicated in terminal differentiation (Eckhart et al, 2000) , was downregulated by TCDD in a concentration-dependent manner. Additionally, processing of pro-caspase-14 to the mature enzyme subunits was readily detectable in control SE but was not observed after TCDD treatment. Western blot analysis of profilaggrin/filaggrin revealed an increase of the abundance of profilaggrin under TCDD exposure. But processing of profilaggrin into mature filaggrin, one of the final steps of KC differentiation, was completely blocked by TCDD.
The results obtained with the SE model support some of the conclusions drawn from studies in other experimental systems, but are in contrast to others. An increased expression of involucrin and profilaggrin has also been reported for monolayer cultures of NHEK (Ray and Swanson, 2003) . In contrast to our results, however, Ray and coworkers observed a decrease in the expression level of p16. In our experiments, TCDD reduced the expression of the differentiation markers keratins 1 and 10. This is in accordance with Rea and coworkers, who reported that TCDD exposure of normal and immortalized human KC in monolayer culture led to a reduction of keratins 1 and 10 mRNA (Rea et al, 1998) . By contrast, topical application of TCDD in adult hairless mice resulted in hyperkeratinization and induction of mouse K1 mRNA expression of the dermal cyst epithelium whereas inter-follicular epidermis was not affected (Panteleyev et al, 1997) . In utero exposure of mouse fetuses to TCDD resulted in an accelerated filaggrin expression as judged immunohistochemically, whereas keratins were not affected (Loertscher et al, 2002) .
Hyperkeratosis in the SE indicates that TCDD accelerates differentiation. This effect is represented in the clinical condition of chloracne in humans, a skin pathology characterized by hyperkeratosis of the sebaceous gland duct, followed by plugging of the follicular orifice and formation of cysts filled with keratinous material (Suskind, 1985; Tindall, 1985) . But regular completion of the differentiation program of human KC is prevented, indicated by parakeratosis and loss of the granular layer. Our data reveal novel effects of TCDD on late steps of terminal KC differentiation, which may contribute to the observed morphogical differences between SE treated and untreated with TCDD. The expression of caspase-14 was strongly reduced and activation of the proenzyme by processing into the subunits did not occur at detectable levels. Even more strikingly, the maturation of profilaggrin into filaggrin monomers was blocked, which probably correlates with the absence of a granular layer.
Although the model system used in this study appears to replicate the in vivo differentiation process of KC more closely than previously reported models, there are still limitations in its predictive value. TCDD may have additional effects in vivo that cannot be seen in an SE model, since several resident and migratory skin cells as well as skin appendages are not present in this model. Further studies are necessary to determine if and how the described TCDD effects at the molecular level contribute to the clinical effects of TCDD on skin. 
Figure 2
Western blot analysis of differentiation markers in TCDD-treated SE. SE exposed to 0, 10 À8 , and 10 À7 M TCDD for 1 wk were analyzed by western blotting for Cyp1A1, p63, Id-1, p16, involucrin (inv), K1/10, caspase-14 (casp-14), filaggrin (fil), and profilaggrin (profil). TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; SE, skin equivalent.
